Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
442.5 USD | +0.42% | +4.55% | +8.63% |
15/05 | Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director | CI |
14/05 | Wolfe Research Adjusts Price Target on Vertex Pharmaceuticals to $520 From $497 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.63% | 11TCr | |
+11.13% | 10TCr | |
-12.76% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-4.18% | 1.79TCr | |
+7.78% | 1.43TCr | |
+35.17% | 1.25TCr | |
-24.86% | 845.25Cr |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Transcript : Vertex Pharmaceuticals Incorporated - Special Call